Superspas RF Injection
By Superspas RF
Rx
2ml Injection in a Ampoule
Composition
Dicyclomine(10mg/ml) + Diclofenac(25mg/ml)
Manufacturer - Seagull Pharmaceutical Pvt Ltd
305-307, Ansal Imperial Tower, C Block Community Centre, Naraina Vihar, New Delhi-110028, India
Expires on or after
July, 2025
Superspas RF Injection should be used carefully in individuals with liver disease. Adjustments in the dosage of Superspas RF Injection may be necessary. It is important to seek advice from your doctor before using this medication. Regular monitoring of liver function tests is suggested for patients with liver disease, especially if the treatment is prolonged.
Superspas RF Injection should be used cautiously in patients with kidney disease. Adjusting the dose may be necessary. Remember to consult your doctor beforehand.
When using Superspas RF Injection, caution is advised when consuming alcohol. It is recommended to consult your doctor about the potential risks associated with combining alcohol and the injection.
When using Superspas RF Injection, be cautious as it can cause side effects like headaches, blurred vision, dizziness, or drowsiness, which may impact your driving ability.
Superspas RF Injection should not be used during pregnancy due to potential risk to the baby. In rare life-threatening cases, a doctor may prescribe it if benefits outweigh risks. Consult your doctor for guidance on safety during pregnancy.
Superspas RF Injection is not recommended during breastfeeding as there is limited evidence suggesting potential harm to the baby through the drug passing into the breastmilk.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹19.3
Inclusive of all taxes
Content verified by
Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025